Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

Member News

Related or similar articles

May 17, 2024

Streamlining Procurement: Labshares Partners with Labviva for Enhanced Access and Efficiency

In the fast-paced world of biotech innovation, easy access to crucial resources is vital for research success. That's why Labshares is excited to share news of our partnership with Labviva, a top procurement platform reshaping how scientists obtain l
Labshares News
November 13, 2025

Labshares Expands to Watertown, Doubling Its Footprint and Bringing Its Shared Lab Model to More Biotechs

With occupancy nearing 90% across its existing facilities, Labshares is expanding to more than 100,000 square feet to meet demand for flexible, capital-efficient lab space that helps biotechs scale smarter and focus on science.
Press Releases
June 13, 2024

Advancing Science at Labshares: Diagonal Therapeutics' Journey

Labshares News